An Efficacy and Safety Study of Bortezomib in Participants Previously Treated for Multiple Myeloma With Limited Kidney Function

NCT00718640 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Study stopped due to lagging enrolment.

Conditions

Multiple Myeloma

Interventions

DRUG: Dexamethasone
DRUG: Bortezomib

Sponsor

Janssen-Ortho Inc., Canada